# OnCo record t-knife (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/t-knife/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "t-knife" ;
  schema:name "T-Knife"@en ;
  schema:alternateName "T-knife"@en, "T-knife Therapeutics"@en, "T-knife GmbH"@en, "T-knife Therapeutics, Inc."@en ;
  schema:description "A Berlin company that engineers patients' T cells with receptors that recognise cancer, aiming at solid tumours. Its lead therapy targets PRAME, a marker found in many cancers, and its first trial is planned for 2026."@en ;
  schema:url <https://onco.cc/companies/t-knife/>, <https://www.t-knife.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.t-knife.com/>, <https://www.t-knife.com/pipeline/>, <https://www.t-knife.com/about/>, <https://www.t-knife.com/imprint/>, <https://clinicaltrials.gov/study/NCT05430555>, <https://www.anderapartners.com/en/expertise/life-sciences-biotechnologies/>, <https://www.racap.com/portfolio/t-knife> ;
  schema:addressCountry "DE" ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/tcr-t/> ;
  onco:targets <https://onco.cc/targets/prame/> .